Reply to Comment on “Artificial Intelligence in Neovascular Age-related Macular Degeneration”

We thank the authors for their thoughtful and constructive comments on our recently published review [1]. We are delighted to see our work resonating with others in the field and greatly appreciate their insightful observations on the transformative potential of artificial intelligence (AI) in managing retinal diseases.

Publikationsverlauf

Artikel online veröffentlicht:
18. September 2025

• References

• 1 Ferro Desideri L, Zinkernagel M, Anguita R. Artificial Intelligence in neovascular age-related macular degeneration. Klin Monbl Augenheilkd 2024;
• 2 Ferro Desideri L, Anguita R, Berger LE. et al. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC RETINAL LAYER FEATURES IDENTIFIED BY ARTIFICIAL INTELLIGENCE PREDICT THE COURSE OF CENTRAL SEROUS CHORIORETINOPATHY. Retina 2024; 44: 316-323
• 3 Ferro Desideri L, Danilovska T, Bernardi E. et al. Artificial Intelligence-Enhanced OCT Biomarkers Analysis in Macula-off Rhegmatogenous Retinal Det achment Patients. Transl Vis Sci Technol 2024; 13: 21